February 20, 2007/
No Comments
Summary: The FDA changed the FUZEON prescribing information to help avoid this common and unpleasant side effect of the drug. —————————————- On January 31 the FDA announced that the FUZEON (enfuvirtide) package insert had been changed to include precautions to avoid injection-site reactions, either using a needle, or the Biojector(r)…